Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lyell Immunopharma, Inc. (LYEL)

Simbol lan logo merek Lyell Immunopharma Inc (LYEL)

Lyell Immunopharma generates revenue through partnerships and future royalties from T-cell therapies for the treatment of solid tumors. The net income per share growth target for the coming year illustrates the sensitivity of forecasts to market changes, and this parameter has settled at 3.40. The company's pricing power is based on immune cell rejuvenation technologies, while its strategy relies on large-scale international trials of CAR-T products.

LYEL - Prakiraan wutah bathi kanggo taun ngarep Lyell Immunopharma Inc ing rentang 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan Lyell Immunopharma Inc (LYEL)

- rega lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Lyell Immunopharma Inc
Barang utama Lyell

Lyell Immunopharma's proprietary T-cell product manufacturing facility reduces production costs, strengthening its fundamental resilience. The earnings per share (EPS) revision history visualizes the consolidated analyst forecast regarding EPS growth rates for the coming year. This trajectory allows investors to filter out market noise, capturing the real dynamics of the business's future profitability. The indicator serves as an objective tool for assessing the asset's investment attractiveness.

Pesaing langsung

Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (immatics.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Compass Bio (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|IPHA - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep PYXS (Pyxis Oncology, Inc.)|Proyeksi tambahing bathi saben saham ing taun ngarep CGEN|Prakiraan wutah bathi kanggo taun ngarep IOBT (IO Biotech)|Dinamika bathi saben saham sing diarepake ing taun ngarep STRO|minktherapeutics.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Werewolf Therapeutics, Inc.|Immix (IMMX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ALX Oncology Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cue Biopharma|Prakiraan wutah bathi kanggo taun ngarep pdsbiotech.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep sonnetbio.com (SONN)|MAIA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Liminatus Pharma Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|LAVA Therapeutics N.V. (LVTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NXTC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Intensity Therapeutics (INTS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Prakiraan wutah bathi kanggo taun ngarep|Gritstone bio (GRTS) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NexImmune Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep turnstonebio.com TSBX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vaccinex Inc (VCNX)|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep